NEW YORK (CNNMoney.com) -- Motor Trend magazine named the 2011 Porsche Cayenne as the winner of its SUV of the Year Award on Tuesday.
The Cayenne, originally introduced in 2002, was redesigned and re-engineered for the 2011 model year.
"Not only are the Cayenne's technical advancements compelling, but its increased fuel efficiency, high value rating, improved interior and exterior design features result in an unbeatable combination of performance and capability," said Motor Trend.
Motor Trend's editorial staff selected vehicles based on advancement in design, engineering excellence, efficiency, safety and value. Testing involves a week-long process including track tests and "real-world" driving.
Motor Trend noted that the Cayenne didn't win the award when it was first introduced but "the technical enhancements made between then and now are compelling."
The SUV's new design looks more compact despite being slightly larger than the previous version, the magazine noted.
"The judges agreed the Porsche Cayenne was a multi-talented crossover vehicle that drove like a Porsche on the road, yet with its height adjustable suspension and computer-controlled four-wheel drive system, was almost as capable as a genuine off-road SUV," the magazine said in its announcement.
The Cayenne is available with a V6 engine, a non-turbocharged or turbocharged V8 engine, or with an all new hybrid powertrain which includes a supercharged V6. The 380-horsepower Cayenne Hybrid gets EPA-estimated fuel economy of 21 mpg in the city and 25 on the highway.
A rarity among SUVs, the V6-powered base Cayenne is available with a six-speed manual transmission. All versions of the Cayenne, including the hybrid, are available with manually shift able 8-speed automatic transmissions.
Cayenne prices start at $47,675, but a fully loaded Cayenne Turbo can cost as much as $168,000, Motor Trend said. A typically equipped mid-priced Cayenne S recently tested by CNNMoney.com was priced at $82,000.
Irish drug maker Mallinckrodt will have to pay a $100 million fine and allow one of its competitors to produce a life-saving medication used to treat infants. The company hiked the price of the drug from $40 per vial to more than $34,000 per vial over the course of about 15 years. More
China and Japan sold a large amount of U.S. Treasury bonds in November. It's not just a reaction to Donald Trump and possible stimulus though. They have been selling bonds for months. If this continues, rates could creep even higher. More
In 1998, Ntsiki Biyela won a scholarship to study wine making. Now she's about to launch her own brand. More
Navient, formerly part of Sallie Mae, was sued by the CFPB Wednesday for allegedly cheating borrowers out of repayment rights. More